JP2005511592A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005511592A5 JP2005511592A5 JP2003541824A JP2003541824A JP2005511592A5 JP 2005511592 A5 JP2005511592 A5 JP 2005511592A5 JP 2003541824 A JP2003541824 A JP 2003541824A JP 2003541824 A JP2003541824 A JP 2003541824A JP 2005511592 A5 JP2005511592 A5 JP 2005511592A5
- Authority
- JP
- Japan
- Prior art keywords
- carbon atoms
- branched
- alkyl
- numbers
- linear
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000004432 carbon atom Chemical group C* 0.000 claims 30
- 125000000217 alkyl group Chemical group 0.000 claims 22
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 10
- 125000003342 alkenyl group Chemical group 0.000 claims 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims 6
- 229910052736 halogen Inorganic materials 0.000 claims 6
- 150000002367 halogens Chemical class 0.000 claims 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 6
- 125000002947 alkylene group Chemical group 0.000 claims 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 4
- 229910052760 oxygen Inorganic materials 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 229910052717 sulfur Inorganic materials 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 3
- 229930184725 Lipoxin Natural products 0.000 claims 2
- 208000019693 Lung disease Diseases 0.000 claims 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 150000002639 lipoxins Chemical class 0.000 claims 2
- 210000004072 lung Anatomy 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33886201P | 2001-11-06 | 2001-11-06 | |
| US39104902P | 2002-06-24 | 2002-06-24 | |
| US10/289,654 US20030166716A1 (en) | 2001-11-06 | 2002-11-06 | Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| PCT/US2002/035860 WO2003039533A1 (en) | 2001-11-06 | 2002-11-06 | Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005320216A Division JP2006063084A (ja) | 2001-11-06 | 2005-11-02 | 喘息および炎症性気道疾患の治療におけるリポキシンおよびアスピリン誘発リポキシンおよびそれらの安定な類似物 |
| JP2010207350A Division JP2010275329A (ja) | 2001-11-06 | 2010-09-15 | 喘息および炎症性気道疾患の治療におけるリポキシンおよびアスピリン誘発リポキシンおよびそれらの安定な類似物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005511592A JP2005511592A (ja) | 2005-04-28 |
| JP2005511592A5 true JP2005511592A5 (https=) | 2006-01-05 |
| JP4652685B2 JP4652685B2 (ja) | 2011-03-16 |
Family
ID=27403915
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003541824A Expired - Fee Related JP4652685B2 (ja) | 2001-11-06 | 2002-11-06 | 喘息および炎症性気道疾患の治療におけるリポキシンおよびアスピリン誘発リポキシンおよびそれらの安定な類似物 |
| JP2005320216A Pending JP2006063084A (ja) | 2001-11-06 | 2005-11-02 | 喘息および炎症性気道疾患の治療におけるリポキシンおよびアスピリン誘発リポキシンおよびそれらの安定な類似物 |
| JP2010207350A Withdrawn JP2010275329A (ja) | 2001-11-06 | 2010-09-15 | 喘息および炎症性気道疾患の治療におけるリポキシンおよびアスピリン誘発リポキシンおよびそれらの安定な類似物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005320216A Pending JP2006063084A (ja) | 2001-11-06 | 2005-11-02 | 喘息および炎症性気道疾患の治療におけるリポキシンおよびアスピリン誘発リポキシンおよびそれらの安定な類似物 |
| JP2010207350A Withdrawn JP2010275329A (ja) | 2001-11-06 | 2010-09-15 | 喘息および炎症性気道疾患の治療におけるリポキシンおよびアスピリン誘発リポキシンおよびそれらの安定な類似物 |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US20030166716A1 (https=) |
| EP (1) | EP1441715B1 (https=) |
| JP (3) | JP4652685B2 (https=) |
| AU (1) | AU2008216965B9 (https=) |
| CA (1) | CA2465117C (https=) |
| WO (1) | WO2003039533A1 (https=) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002539181A (ja) | 1999-03-18 | 2002-11-19 | ブリガム・アンド・ウイメンズ・ホスピタル | リポキシン化合物およびこれらの使用 |
| EP1586550A1 (en) * | 1999-03-18 | 2005-10-19 | The Brigham And Women's Hospital, Inc. | Lipoxin compounds and their use |
| EP1762557B1 (en) | 2000-02-16 | 2011-04-06 | The Brigham And Women's Hospital, Inc. | Aspirin-triggered lipid mediators |
| US7700650B2 (en) | 2000-03-20 | 2010-04-20 | Trustees Of Boston University | Lipoxin analogs and method for the treatment of periodontal disease |
| US20030166716A1 (en) * | 2001-11-06 | 2003-09-04 | Serhan Charles N. | Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| CA2467580C (en) | 2001-12-18 | 2012-10-30 | Brigham And Women's Hospital | Use of lipoxin analogs to promote cell defense against gram-negative infections |
| US7902257B2 (en) * | 2002-04-01 | 2011-03-08 | University Of Southern California | Trihydroxy polyunsaturated eicosanoid |
| US8481772B2 (en) | 2002-04-01 | 2013-07-09 | University Of Southern California | Trihydroxy polyunsaturated eicosanoid derivatives |
| US7759395B2 (en) | 2002-08-12 | 2010-07-20 | The Brigham And Women's Hospital, Inc. | Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma |
| DE60330154D1 (de) * | 2002-08-12 | 2009-12-31 | Brigham & Womens Hospital | Resolvine: biotemplate zur durchführung therapeutischer anwendungen |
| WO2004078143A2 (en) * | 2003-03-05 | 2004-09-16 | The Brigham And Women's Hospital Inc. | Methods for identification and uses of anti-inflammatory receptors for eicosapentaenoic acid analogs |
| WO2004110426A1 (en) * | 2003-06-01 | 2004-12-23 | Petasis Nicos A | Modulation of airway inflammation in patients with cystic fibrosis and related diseases |
| EP1755537A4 (en) * | 2004-04-14 | 2009-12-09 | Univ Boston | METHOD AND COMPOSITIONS FOR PREVENTING OR TREATING PERIODONTOPATHIA |
| WO2007041440A2 (en) | 2005-10-03 | 2007-04-12 | The Brigham And Women's Hospital, Inc. | Anti-inflammatory actions of neuroprotectin d1/protectin d1 and its natural stereoisomers |
| US7687539B1 (en) | 2005-11-07 | 2010-03-30 | Alcon Research, Ltd. | Method of treating ocular allergy |
| US8636986B2 (en) * | 2005-11-18 | 2014-01-28 | The Forsyth Institute | Treatment and prevention of bone loss using resolvins |
| WO2009017802A1 (en) | 2007-08-01 | 2009-02-05 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Nitro-fattyacid modulation of type ii diabetes |
| GB0802116D0 (en) * | 2008-02-05 | 2008-03-12 | Natural Enviromental Res Counc | Treatment |
| JP2011519373A (ja) | 2008-05-01 | 2011-07-07 | コンプレクザ インコーポレイテッド | ビニル置換脂肪酸 |
| US20140024713A1 (en) | 2008-06-19 | 2014-01-23 | University Of Utah Research Foundation | Use of nitrated lipids for treatment of side effects of toxic medical therapies |
| EP2393353A4 (en) * | 2009-02-05 | 2013-12-25 | Resolvyx Pharmaceuticals Inc | COMPOSITIONS AND METHODS OF ORGAN CONSERVATION |
| EP3045167A1 (en) | 2009-07-31 | 2016-07-20 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Keto fatty acids as anti-inflammatory agents |
| EP2483233A4 (en) | 2009-10-02 | 2013-08-14 | Complexa Inc | HETEROATOMA CONTAINING SUBSTITUTED FATTY ACIDS |
| WO2011050126A1 (en) * | 2009-10-21 | 2011-04-28 | University Of Medicine And Dentistry Of New Jersey | Method for treating sepsis or septic shock |
| WO2013028501A1 (en) | 2011-08-19 | 2013-02-28 | The University Of Utah Research Foundation | Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system |
| WO2014039223A1 (en) * | 2012-09-07 | 2014-03-13 | The Brigham And Women's Hospital, Inc. | Diagnosis and treatment of aspirin-exacerbated respiratory disease (aerd) |
| PT3865484T (pt) | 2015-07-07 | 2024-01-30 | H Lundbeck As | Inibidor da pde9 com esqueleto de imidazo pirazinona para tratamento de doenças periféricas |
| WO2017059451A1 (en) | 2015-10-02 | 2017-04-06 | Complexa, Inc. | Prevention, treatment and reversal of disease using therapeutically effective amounts of activated fatty acids |
| ES2827796T3 (es) | 2016-06-03 | 2021-05-24 | Thetis Pharmaceuticals Llc | Composiciones y procedimientos relativos a sales de mediadores pro-resolutivos especializados de inflamación |
| WO2018144316A1 (en) | 2017-01-31 | 2018-08-09 | The Brigham And Women's Hospital, Inc. | Alx receptor ligands define a biochemical endotype for inflammation-based diseases |
| WO2018161175A1 (en) | 2017-03-09 | 2018-09-13 | University Health Network | Lipoxin and lipoxin analogue mediated neuroprotection and treatments |
| CA3100988A1 (en) | 2018-05-25 | 2019-11-28 | Imara Inc. | Monohydrate and crystalline forms of 6-[(3s,4s)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7h-imidazo[1,5-a]pyrazin-8-one |
| CA3110680A1 (en) | 2018-08-31 | 2020-03-05 | Imara Inc. | Pde9 inhibitors for treating sickle cell disease |
| WO2020076578A1 (en) | 2018-10-09 | 2020-04-16 | University Of Rochester | Treatment of vulvovaginal disorders |
| WO2023168245A2 (en) | 2022-03-03 | 2023-09-07 | Thetis Pharmaceuticals Llc | Cyclodextrin complexes of specialized proresolving mediators |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4560514A (en) * | 1984-05-04 | 1985-12-24 | Bengt Samuelsson | Inflammatory lipoxin A and anti-anflammatory lipoxin B compounds |
| US4576758A (en) * | 1984-06-01 | 1986-03-18 | The Upjohn Company | Anti-inflammatory lipoxin B analogs |
| US4780281A (en) * | 1985-06-14 | 1988-10-25 | Wayne State University | Method for assay of peroxidase enzyme or reducing substrate activity |
| US5385938B1 (en) * | 1986-12-23 | 1997-07-15 | Tristrata Inc | Method of using glycolic acid for treating wrinkles |
| CA1329809C (en) * | 1987-07-08 | 1994-05-24 | Nissan Chemical Industries, Ltd. | Optically active allyl alcohol and process for producing leucotriene b_ using thereof |
| US5079261A (en) * | 1989-04-28 | 1992-01-07 | Brigham And Women's Hospital | Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| US5322699A (en) * | 1991-02-04 | 1994-06-21 | The Rockefeller University | Leukocyte-derived CR3 modulator, integrin modulating factor-1 (IMF-1) |
| US5650435A (en) * | 1991-04-01 | 1997-07-22 | Madara; James L. | Modulation of inflammation related to columnar epithelia |
| DE69435125D1 (de) * | 1993-06-15 | 2008-10-02 | Brigham & Womens Hospital | Lipoxinverbindungen mit verlängerter halbwertszeit |
| US5441951A (en) * | 1994-06-15 | 1995-08-15 | Brigham & Women's Hospital | Lipoxin compounds |
| US6048897A (en) * | 1993-06-15 | 2000-04-11 | Brigham And Women's Hospital | Lipoxin compounds and their use in treating cell proliferative disorders |
| WO1995001179A1 (en) | 1993-06-29 | 1995-01-12 | Brigham & Women's Hospital | Modulation of inflammation related to columnar epithelia |
| US5837699A (en) * | 1994-01-27 | 1998-11-17 | Schering Corporation | Use of mometasone furoate for treating upper airway passage diseases |
| US5674483A (en) * | 1995-01-31 | 1997-10-07 | National Jewish Medical And Research Center | Treatment for diseases involving inflammation |
| US5998487A (en) * | 1998-04-08 | 1999-12-07 | Colgate-Palmolive Company | Anti-inflammatory and antibacterial benzyl phenol agents and their use in oral compositions |
| CA2339049C (en) | 1998-09-08 | 2010-02-23 | Cornell Research Foundation, Inc. | Treating inflammatory diseases of the head and neck with cyclooxygenase-2 inhibitors |
| US6353026B1 (en) * | 1999-03-18 | 2002-03-05 | Brigham And Women's Hospital | Regulation of phospholipase D activity |
| JP2002539181A (ja) * | 1999-03-18 | 2002-11-19 | ブリガム・アンド・ウイメンズ・ホスピタル | リポキシン化合物およびこれらの使用 |
| CA2367909C (en) * | 1999-03-18 | 2008-02-12 | Brigham And Women's Hospital | Use of lipoxin compounds for inhibiting of tnf-(alpha) initiated neutrophil response |
| US7700650B2 (en) | 2000-03-20 | 2010-04-20 | Trustees Of Boston University | Lipoxin analogs and method for the treatment of periodontal disease |
| US6495596B1 (en) * | 2001-03-23 | 2002-12-17 | Biozibe Laboratories, Inc. | Compounds and methods for inhibition of phospholipase A2 and cyclooxygenase-2 |
| US20030166716A1 (en) * | 2001-11-06 | 2003-09-04 | Serhan Charles N. | Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| US6831186B2 (en) * | 2001-11-06 | 2004-12-14 | Schering Aktiengesellschft | Lipoxin A4 analogs |
-
2002
- 2002-11-06 US US10/289,654 patent/US20030166716A1/en not_active Abandoned
- 2002-11-06 CA CA2465117A patent/CA2465117C/en not_active Expired - Fee Related
- 2002-11-06 WO PCT/US2002/035860 patent/WO2003039533A1/en not_active Ceased
- 2002-11-06 EP EP02789515A patent/EP1441715B1/en not_active Expired - Lifetime
- 2002-11-06 JP JP2003541824A patent/JP4652685B2/ja not_active Expired - Fee Related
-
2005
- 2005-11-02 JP JP2005320216A patent/JP2006063084A/ja active Pending
- 2005-11-17 US US11/281,132 patent/US8119691B2/en not_active Expired - Fee Related
-
2007
- 2007-08-13 US US11/837,674 patent/US20080064746A1/en not_active Abandoned
-
2008
- 2008-09-11 AU AU2008216965A patent/AU2008216965B9/en not_active Ceased
-
2010
- 2010-09-15 JP JP2010207350A patent/JP2010275329A/ja not_active Withdrawn
-
2012
- 2012-02-21 US US13/401,519 patent/US20120149771A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005511592A5 (https=) | ||
| JP2002539156A5 (https=) | ||
| JP2002539181A5 (https=) | ||
| JP2002539159A5 (https=) | ||
| JP2005533835A5 (https=) | ||
| JP2001526218A5 (https=) | ||
| JP2002533472A5 (https=) | ||
| JPH10279578A5 (https=) | ||
| RU2000132188A (ru) | Производные эпотилонов, их синтез и применение | |
| KR920009796A (ko) | 3-아미도인돌릴 유도체 | |
| JP2002508347A5 (https=) | ||
| JP2002505323A5 (https=) | ||
| RU2005100836A (ru) | Производные пептидов, содержащие тиазепиновую группу, для лечения гиперлипемических состояний | |
| RU99128073A (ru) | Замещенные 2-(2,6-диоксопиперидин-3-ил)-фталимиды и -1-оксоизоиндолины и способ снижения уровней фноа | |
| CA2465117A1 (en) | Lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases | |
| JP2009536660A5 (https=) | ||
| HU9300274D0 (en) | Phosphonoxical as well as carbonatic derivatives of taxole and medical preparatives containing said active substance | |
| JP2005511699A5 (https=) | ||
| RU98120057A (ru) | Производные d-пролина | |
| RU95117068A (ru) | Антигипертриглицеридемическая композиция, способ ее получения, способ лечения или профилактики гипертриглицеридемии, применение соединений | |
| JP2004537516A5 (https=) | ||
| JP2004507521A5 (https=) | ||
| JP2004524316A5 (https=) | ||
| RU2001116117A (ru) | Новые пиперазиновые и пиперидиновые соединения | |
| JPH10287651A5 (https=) |